{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T03:17:01Z","timestamp":1787455021815,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s11307-025-02047-8","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T14:19:04Z","timestamp":1757686744000},"page":"832-838","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of Age and BMI on Histamine H3 Receptor Availability in Healthy Humans"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6816-1252","authenticated-orcid":false,"given":"Yanghong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Gravel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Pittman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Hoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Cool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faranak Ebrahimian","family":"Sadabad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Qiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Pittenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Dominique","family":"Gallezot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Matuskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,12]]},"reference":[{"key":"2047_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.neuroscience.2004.12.017","volume":"132","author":"CY Jin","year":"2005","unstructured":"Jin CY, Panula P (2005) The laminar histamine receptor system in human prefrontal cortex suggests multiple levels of histaminergic regulation. Neuroscience 132:137\u2013149. https:\/\/doi.org\/10.1016\/j.neuroscience.2004.12.017","journal-title":"Neuroscience"},{"key":"2047_CR2","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1006\/nbdi.2001.0413","volume":"8","author":"OV Anichtchik","year":"2001","unstructured":"Anichtchik OV, Peitsaro N, Rinne JO, Kalimo H, Panula P (2001) Distribution and modulation of histamine H(3) receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson\u2019s disease. Neurobiol Dis 8:707\u2013716. https:\/\/doi.org\/10.1006\/nbdi.2001.0413","journal-title":"Neurobiol Dis"},{"key":"2047_CR3","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/302832a0","volume":"302","author":"JM Arrang","year":"1983","unstructured":"Arrang JM, Garbarg M, Schwartz JC (1983) Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 302:832\u2013837. https:\/\/doi.org\/10.1038\/302832a0","journal-title":"Nature"},{"key":"2047_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nrd1631","volume":"4","author":"R Leurs","year":"2005","unstructured":"Leurs R, Bakker RA, Timmerman H, de Esch IJ (2005) The histamine H3 receptor: from gene cloning to H3 receptor drugs. Nat Rev Drug Discov 4:107\u2013120. https:\/\/doi.org\/10.1038\/nrd1631","journal-title":"Nat Rev Drug Discov"},{"key":"2047_CR5","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/j.1472-8206.1994.tb00789.x","volume":"8","author":"E Schlicker","year":"1994","unstructured":"Schlicker E, Malinowska B, Kathmann M, Gothert M (1994) Modulation of neurotransmitter release via histamine H3 heteroreceptors. Fundam Clin Pharmacol 8:128\u2013137. https:\/\/doi.org\/10.1111\/j.1472-8206.1994.tb00789.x","journal-title":"Fundam Clin Pharmacol"},{"key":"2047_CR6","doi-asserted-by":"publisher","first-page":"9965","DOI":"10.1073\/pnas.181330998","volume":"98","author":"ZL Huang","year":"2001","unstructured":"Huang ZL, Qu WM, Li WD, Mochizuki T, Eguchi N, Watanabe T, Urade Y, Hayaishi O (2001) Arousal effect of orexin A depends on activation of the histaminergic system. Proc Natl Acad Sci U S A 98:9965\u20139970. https:\/\/doi.org\/10.1073\/pnas.181330998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2047_CR7","doi-asserted-by":"publisher","first-page":"7695","DOI":"10.1523\/JNEUROSCI.22-17-07695.2002","volume":"22","author":"R Parmentier","year":"2002","unstructured":"Parmentier R, Ohtsu H, Djebbara-Hannas Z, Valatx JL, Watanabe T, Lin JS (2002) Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. J Neurosci 22:7695\u20137711","journal-title":"J Neurosci"},{"key":"2047_CR8","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/0006-8993(89)91161-x","volume":"493","author":"CA Cornwell-Jones","year":"1989","unstructured":"Cornwell-Jones CA, Decker MW, Chang JW, Cole B, Goltz KM, Tran T, McGaugh JL (1989) Neonatal 6-hydroxydopa, but not DSP-4, elevates brainstem monoamines and impairs inhibitory avoidance learning in developing rats. Brain Res 493:258\u2013268. https:\/\/doi.org\/10.1016\/0006-8993(89)91161-x","journal-title":"Brain Res"},{"key":"2047_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0163-1047(92)90315-u","volume":"58","author":"T Sagvolden","year":"1992","unstructured":"Sagvolden T, Metzger MA, Schiorbeck HK, Rugland AL, Spinnangr I, Sagvolden G (1992) The spontaneously hypertensive rat (SHR) as an animal model of childhood hyperactivity (ADHD): changed reactivity to reinforcers and to psychomotor stimulants. Behav Neural Biol 58:103\u2013112. https:\/\/doi.org\/10.1016\/0163-1047(92)90315-u","journal-title":"Behav Neural Biol"},{"key":"2047_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/s0149-7634(99)00058-5","volume":"24","author":"T Sagvolden","year":"2000","unstructured":"Sagvolden T (2000) Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit\/hyperactivity disorder (AD\/HD). Neurosci Biobehav Rev 24:31\u201339. https:\/\/doi.org\/10.1016\/s0149-7634(99)00058-5","journal-title":"Neurosci Biobehav Rev"},{"key":"2047_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ejphar.2003.09.066","volume":"482","author":"L Zhang","year":"2003","unstructured":"Zhang L, Chen Z, Ren K, Leurs R, Chen J, Zhang W, Ye B, Wei E, Timmerman H (2003) Effects of clobenpropit on pentylenetetrazole-kindled seizures in rats. Eur J Pharmacol 482:169\u2013175. https:\/\/doi.org\/10.1016\/j.ejphar.2003.09.066","journal-title":"Eur J Pharmacol"},{"key":"2047_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/s0014-2999(03)01737-0","volume":"470","author":"KE Cannon","year":"2003","unstructured":"Cannon KE, Nalwalk JW, Stadel R, Ge P, Lawson D, Silos-Santiago I, Hough LB (2003) Activation of spinal histamine H3 receptors inhibits mechanical nociception. Eur J Pharmacol 470:139\u2013147. https:\/\/doi.org\/10.1016\/s0014-2999(03)01737-0","journal-title":"Eur J Pharmacol"},{"key":"2047_CR13","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1111\/j.1476-5381.1994.tb14883.x","volume":"111","author":"P Malmberg-Aiello","year":"1994","unstructured":"Malmberg-Aiello P, Lamberti C, Ghelardini C, Giotti A, Bartolini A (1994) Role of histamine in rodent antinociception. Br J Pharmacol 111:1269\u20131279. https:\/\/doi.org\/10.1111\/j.1476-5381.1994.tb14883.x","journal-title":"Br J Pharmacol"},{"key":"2047_CR14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/0006-8993(95)00542-x","volume":"690","author":"P Ghi","year":"1995","unstructured":"Ghi P, Ferretti C, Blengio M (1995) Effects of different types of stress on histamine-H3 receptors in the rat cortex. Brain Res 690:104\u2013107. https:\/\/doi.org\/10.1016\/0006-8993(95)00542-x","journal-title":"Brain Res"},{"key":"2047_CR15","doi-asserted-by":"publisher","first-page":"9273","DOI":"10.1523\/JNEUROSCI.21-23-09273.2001","volume":"21","author":"KS Eriksson","year":"2001","unstructured":"Eriksson KS, Sergeeva O, Brown RE, Haas HL (2001) Orexin\/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J Neurosci 21:9273\u20139279","journal-title":"J Neurosci"},{"key":"2047_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ejphar.2004.01.015","volume":"487","author":"AA Hancock","year":"2004","unstructured":"Hancock AA, Bennani YL, Bush EN, Esbenshade TA, Faghih R, Fox GB, Jacobson P, Knourek-Segel V, Krueger KM, Nuss ME, Pan JB, Shapiro R, Witte DG, Yao BB (2004) Antiobesity effects of A-331440, a novel non-imidazole histamine H3 receptor antagonist. Eur J Pharmacol 487:183\u2013197. https:\/\/doi.org\/10.1016\/j.ejphar.2004.01.015","journal-title":"Eur J Pharmacol"},{"key":"2047_CR17","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1038\/bjp.2008.147","volume":"154","author":"TA Esbenshade","year":"2008","unstructured":"Esbenshade TA, Browman KE, Bitner RS, Strakhova M, Cowart MD, Brioni JD (2008) The histamine H3 receptor: an attractive target for the treatment of cognitive disorders. Br J Pharmacol 154:1166\u20131181. https:\/\/doi.org\/10.1038\/bjp.2008.147","journal-title":"Br J Pharmacol"},{"key":"2047_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2004.05.001","volume":"103","author":"JM Witkin","year":"2004","unstructured":"Witkin JM, Nelson DL (2004) Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system. Pharmacol Ther 103:1\u201320. https:\/\/doi.org\/10.1016\/j.pharmthera.2004.05.001","journal-title":"Pharmacol Ther"},{"key":"2047_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.neulet.2003.10.061","volume":"355","author":"A Terao","year":"2004","unstructured":"Terao A, Steininger TL, Morairty SR, Kilduff TS (2004) Age-related changes in histamine receptor mRNA levels in the mouse brain. Neurosci Lett 355:81\u201384. https:\/\/doi.org\/10.1016\/j.neulet.2003.10.061","journal-title":"Neurosci Lett"},{"key":"2047_CR20","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.phrs.2016.08.034","volume":"113","author":"NL Lethbridge","year":"2016","unstructured":"Lethbridge NL, Chazot PL (2016) Ligand autoradiographical quantification of histamine H(3) receptor in human dementia with Lewy bodies. Pharmacol Res 113:245\u2013256. https:\/\/doi.org\/10.1016\/j.phrs.2016.08.034","journal-title":"Pharmacol Res"},{"key":"2047_CR21","doi-asserted-by":"publisher","first-page":"119674","DOI":"10.1016\/j.neuroimage.2022.119674","volume":"264","author":"R Radhakrishnan","year":"2022","unstructured":"Radhakrishnan R, Worhunsky PD, Zheng MQ, Najafzadeh S, Gallezot JD, Planeta B, Henry S, Nabulsi N, Ranganathan M, Skosnik PD, Pittman B, Cyril D\u2019Souza D, Carson RE, Huang Y, Potenza MN, Matuskey D (2022) Age, gender and body-mass-index relationships with in vivo CB(1) receptor availability in healthy humans measured with [(11)C]OMAR PET. Neuroimage 264:119674. https:\/\/doi.org\/10.1016\/j.neuroimage.2022.119674","journal-title":"Neuroimage"},{"key":"2047_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108514","volume":"220","author":"D Matuskey","year":"2021","unstructured":"Matuskey D, Angarita GA, Worhunsky P, Koohsari S, Gravel P, Pittman B, Gaiser EC, Gallezot JD, Nabulsi N, Huang Y, Carson RE, Potenza MN, Malison RT (2021) Dopamine D(2\/3) receptor availability in cocaine use disorder individuals with obesity as measured by [(11)C]PHNO PET. Drug Alcohol Depend 220:108514. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.108514","journal-title":"Drug Alcohol Depend"},{"key":"2047_CR23","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1038\/npp.2016.115","volume":"41","author":"EC Gaiser","year":"2016","unstructured":"Gaiser EC, Gallezot JD, Worhunsky PD, Jastreboff AM, Pittman B, Kantrovitz L, Angarita GA, Cosgrove KP, Potenza MN, Malison RT, Carson RE, Matuskey D (2016) Elevated dopamine D(2\/3) receptor availability in obese individuals: a PET imaging study with [(11)C](+)PHNO. Neuropsychopharmacology 41:3042\u20133050. https:\/\/doi.org\/10.1038\/npp.2016.115","journal-title":"Neuropsychopharmacology"},{"key":"2047_CR24","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1007\/s00259-019-04403-7","volume":"46","author":"J Tuisku","year":"2019","unstructured":"Tuisku J, Plaven-Sigray P, Gaiser EC, Airas L, Al-Abdulrasul H, Bruck A, Carson RE, Chen MK, Cosgrove KP, Ekblad L, Esterlis I, Farde L, Forsberg A, Halldin C, Helin S, Kosek E, Lekander M, Lindgren N, Marjamaki P, Rissanen E, Sucksdorff M, Varrone A, group HPs, Collste K, Gallezot JD, Hillmer A, Huang Y, Hoglund CO, Johansson J, Jucaite A, Lampa J, Nabulsi N, Pittman B, Sandiego CM, Stenkrona P, Rinne J, Matuskey D, Cervenka S (2019) Effects of age, BMI and sex on the glial cell marker TSPO - a multicentre [(11)C]PBR28 HRRT PET study. Eur J Nucl Med Mol Imaging 46:2329\u20132338. https:\/\/doi.org\/10.1007\/s00259-019-04403-7","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2047_CR25","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1111\/j.1476-5381.2012.02056.x","volume":"167","author":"RH Clapp","year":"2012","unstructured":"Clapp RH, Luckman SM (2012) Proxyfan acts as a neutral antagonist of histamine H3 receptors in the feeding-related hypothalamic ventromedial nucleus. Br J Pharmacol 167:1099\u20131110. https:\/\/doi.org\/10.1111\/j.1476-5381.2012.02056.x","journal-title":"Br J Pharmacol"},{"key":"2047_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000090982","volume":"82","author":"EA Jorgensen","year":"2005","unstructured":"Jorgensen EA, Knigge U, Watanabe T, Warberg J, Kjaer A (2005) Histaminergic neurons are involved in the orexigenic effect of orexin-A. Neuroendocrinology 82:70\u201377. https:\/\/doi.org\/10.1159\/000090982","journal-title":"Neuroendocrinology"},{"key":"2047_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.neuropharm.2015.07.002","volume":"106","author":"G Provensi","year":"2016","unstructured":"Provensi G, Blandina P, Passani MB (2016) The histaminergic system as a target for the prevention of obesity and metabolic syndrome. Neuropharmacology 106:3\u201312. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.07.002","journal-title":"Neuropharmacology"},{"key":"2047_CR28","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00210-018-1516-2","volume":"391","author":"M Kotanska","year":"2018","unstructured":"Kotanska M, Kuder KJ, Szczepanska K, Sapa J, Kiec-Kononowicz K (2018) The histamine H(3) receptor inverse agonist pitolisant reduces body weight in obese mice. Naunyn Schmiedebergs Arch Pharmacol 391:875\u2013881. https:\/\/doi.org\/10.1007\/s00210-018-1516-2","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2047_CR29","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.2967\/jnumed.109.062919","volume":"50","author":"C Plisson","year":"2009","unstructured":"Plisson C, Gunn RN, Cunningham VJ, Bender D, Salinas CA, Medhurst AD, Roberts JC, Laruelle M, Gee AD (2009) 11C-GSK189254: a selective radioligand for in vivo central nervous system imaging of histamine H3 receptors by PET. J Nucl Med 50:2064\u20132072. https:\/\/doi.org\/10.2967\/jnumed.109.062919","journal-title":"J Nucl Med"},{"key":"2047_CR30","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/nimg.2001.0978","volume":"15","author":"N Tzourio-Mazoyer","year":"2002","unstructured":"Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M (2002) Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15:273\u2013289. https:\/\/doi.org\/10.1006\/nimg.2001.0978","journal-title":"Neuroimage"},{"key":"2047_CR31","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1177\/0271678X16650697","volume":"37","author":"JD Gallezot","year":"2017","unstructured":"Gallezot JD, Planeta B, Nabulsi N, Palumbo D, Li X, Liu J, Rowinski C, Chidsey K, Labaree D, Ropchan J, Lin SF, Sawant-Basak A, McCarthy TJ, Schmidt AW, Huang Y, Carson RE (2017) Determination of receptor occupancy in the presence of mass dose: [(11)C]GSK189254 PET imaging of histamine H(3) receptor occupancy by PF-03654746. J Cereb Blood Flow Metab 37:1095\u20131107. https:\/\/doi.org\/10.1177\/0271678X16650697","journal-title":"J Cereb Blood Flow Metab"},{"key":"2047_CR32","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/s0969-8051(00)00125-6","volume":"27","author":"J Hilton","year":"2000","unstructured":"Hilton J, Yokoi F, Dannals RF, Ravert HT, Szabo Z, Wong DF (2000) Column-switching HPLC for the analysis of plasma in PET imaging studies. Nucl Med Biol 27:627\u2013630. https:\/\/doi.org\/10.1016\/s0969-8051(00)00125-6","journal-title":"Nucl Med Biol"},{"key":"2047_CR33","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.2967\/jnumed.109.071753","volume":"51","author":"S Ashworth","year":"2010","unstructured":"Ashworth S, Rabiner EA, Gunn RN, Plisson C, Wilson AA, Comley RA, Lai RY, Gee AD, Laruelle M, Cunningham VJ (2010) Evaluation of 11C-GSK189254 as a novel radioligand for the H3 receptor in humans using PET. J Nucl Med 51:1021\u20131029. https:\/\/doi.org\/10.2967\/jnumed.109.071753","journal-title":"J Nucl Med"},{"key":"2047_CR34","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.biopsych.2013.11.022","volume":"76","author":"D Matuskey","year":"2014","unstructured":"Matuskey D, Bhagwagar Z, Planeta B, Pittman B, Gallezot JD, Chen J, Wanyiri J, Najafzadeh S, Ropchan J, Geha P, Huang Y, Potenza MN, Neumeister A, Carson RE, Malison RT (2014) Reductions in brain 5-HT1B receptor availability in primarily cocaine-dependent humans. Biol Psychiatry 76:816\u2013822. https:\/\/doi.org\/10.1016\/j.biopsych.2013.11.022","journal-title":"Biol Psychiatry"},{"key":"2047_CR35","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.2967\/jnumed.112.103598","volume":"53","author":"D Matuskey","year":"2012","unstructured":"Matuskey D, Pittman B, Planeta-Wilson B, Walderhaug E, Henry S, Gallezot JD, Nabulsi N, Ding YS, Bhagwagar Z, Malison R, Carson RE, Neumeister A (2012) Age effects on serotonin receptor 1B as assessed by PET. J Nucl Med 53:1411\u20131414. https:\/\/doi.org\/10.2967\/jnumed.112.103598","journal-title":"J Nucl Med"},{"key":"2047_CR36","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.neuroimage.2016.02.002","volume":"130","author":"D Matuskey","year":"2016","unstructured":"Matuskey D, Worhunksy P, Correa E, Pittman B, Gallezot JD, Nabulsi N, Ropchan J, Sreeram V, Gudepu R, Gaiser E, Cosgrove K, Ding YS, Potenza MN, Huang Y, Malison RT, Carson RE (2016) Age-related changes in binding of the D2\/3 receptor radioligand [(11)C](+)PHNO in healthy volunteers. Neuroimage 130:241\u2013247. https:\/\/doi.org\/10.1016\/j.neuroimage.2016.02.002","journal-title":"Neuroimage"},{"key":"2047_CR37","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/00001756-199205000-00014","volume":"3","author":"K Yanai","year":"1992","unstructured":"Yanai K, Watanabe T, Meguro K, Yokoyama H, Sato I, Sasano H, Itoh M, Iwata R, Takahashi T, Ido T (1992) Age-dependent decrease in histamine H1 receptor in human brains revealed by PET. NeuroReport 3:433\u2013436. https:\/\/doi.org\/10.1097\/00001756-199205000-00014","journal-title":"NeuroReport"},{"key":"2047_CR38","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1177\/02698811231177287","volume":"37","author":"A Arumuham","year":"2023","unstructured":"Arumuham A, Nour MM, Veronese M, Onwordi EC, Rabiner EA, Howes OD (2023) The histamine system and cognitive function: an in vivo H3 receptor PET imaging study in healthy volunteers and patients with schizophrenia. J Psychopharmacol 37:1011\u20131022. https:\/\/doi.org\/10.1177\/02698811231177287","journal-title":"J Psychopharmacol"},{"key":"2047_CR39","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13550-018-0406-4","volume":"8","author":"T Ito","year":"2018","unstructured":"Ito T, Kimura Y, Seki C, Ichise M, Yokokawa K, Kawamura K, Takahashi H, Higuchi M, Zhang MR, Suhara T, Yamada M (2018) Histamine H(3) receptor density is negatively correlated with neural activity related to working memory in humans. EJNMMI Res 8:48. https:\/\/doi.org\/10.1186\/s13550-018-0406-4","journal-title":"EJNMMI Res"},{"key":"2047_CR40","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1476-5381.2008.00075.x","volume":"157","author":"AD Medhurst","year":"2009","unstructured":"Medhurst AD, Roberts JC, Lee J, Chen CP, Brown SH, Roman S, Lai MK (2009) Characterization of histamine H3 receptors in Alzheimer\u2019s disease brain and amyloid over-expressing TASTPM mice. Br J Pharmacol 157:130\u2013138. https:\/\/doi.org\/10.1111\/j.1476-5381.2008.00075.x","journal-title":"Br J Pharmacol"},{"key":"2047_CR41","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3233\/jad-150393","volume":"48","author":"M Kubo","year":"2015","unstructured":"Kubo M, Kishi T, Matsunaga S, Iwata N (2015) Histamine H3 receptor antagonists for Alzheimer\u2019s disease: a systematic review and meta-analysis of randomized placebo-controlled trials. J Alzheimers Dis 48:667\u2013671. https:\/\/doi.org\/10.3233\/jad-150393","journal-title":"J Alzheimers Dis"},{"key":"2047_CR42","doi-asserted-by":"publisher","first-page":"959","DOI":"10.3233\/jad-140291","volume":"42","author":"GM Haig","year":"2014","unstructured":"Haig GM, Pritchett Y, Meier A, Othman AA, Hall C, Gault LM, Lenz RA (2014) A randomized study of H3 antagonist ABT-288 in mild-to-moderate Alzheimer\u2019s dementia. J Alzheimers Dis 42:959\u2013971. https:\/\/doi.org\/10.3233\/jad-140291","journal-title":"J Alzheimers Dis"},{"key":"2047_CR43","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.pharmthera.2019.04.007","volume":"200","author":"N Ghamari","year":"2019","unstructured":"Ghamari N, Zarei O, Arias-Monta\u00f1o JA, Reiner D, Dastmalchi S, Stark H, Hamzeh-Mivehroud M (2019) Histamine H(3) receptor antagonists\/inverse agonists: where do they go? Pharmacol Ther 200:69\u201384. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.04.007","journal-title":"Pharmacol Ther"},{"key":"2047_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2021.116462","volume":"50","author":"M Falkenstein","year":"2021","unstructured":"Falkenstein M, Reiner-Link D, Zivkovic A, Gering I, Willbold D, Stark H (2021) Histamine H(3) receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit A\u03b2 oligomerisation. Bioorg Med Chem 50:116462. https:\/\/doi.org\/10.1016\/j.bmc.2021.116462","journal-title":"Bioorg Med Chem"},{"key":"2047_CR45","doi-asserted-by":"publisher","first-page":"12765","DOI":"10.1002\/anie.201706072","volume":"56","author":"\u00d3M Bautista-Aguilera","year":"2017","unstructured":"Bautista-Aguilera \u00d3M, Hagenow S, Palomino-Antolin A, Farr\u00e9-Alins V, Ismaili L, Joffrin PL, Jimeno ML, Soukup O, Jano\u010dkov\u00e1 J, Kalinowsky L, Proschak E, Iriepa I, Moraleda I, Schwed JS, Romero Mart\u00ednez A, L\u00f3pez-Mu\u00f1oz F, Chioua M, Egea J, Ramsay RR, Marco-Contelles J, Stark H (2017) Multitarget-directed ligands combining cholinesterase and monoamine oxidase inhibition with histamine H(3) R antagonism for neurodegenerative diseases. Angew Chem Int Ed Engl 56:12765\u201312769. https:\/\/doi.org\/10.1002\/anie.201706072","journal-title":"Angew Chem Int Ed Engl"},{"key":"2047_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01583","author":"N Wang","year":"2020","unstructured":"Wang N, Ma J, Liu J, Wang J, Liu C, Wang H, Liu Y, Yan H, Jiang S (2020) Histamine H3 receptor antagonist enhances neurogenesis and improves chronic cerebral hypoperfusion-induced cognitive impairments. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2019.01583","journal-title":"Front Pharmacol"},{"key":"2047_CR47","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1177\/0269881116645301","volume":"30","author":"O Spiegelstein","year":"2016","unstructured":"Spiegelstein O, Stevens J, Van Gerven J, Nathan PJ, Maynard JP, Mayleben DW, Hellriegel E, Yang R (2016) Pharmacokinetics, pharmacodynamics and safety of CEP-26401, a high-affinity histamine-3 receptor antagonist, following single and multiple dosing in healthy subjects. J Psychopharmacol 30:983\u2013993. https:\/\/doi.org\/10.1177\/0269881116645301","journal-title":"J Psychopharmacol"},{"key":"2047_CR48","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/bcp.13885","volume":"85","author":"AC Baakman","year":"2019","unstructured":"Baakman AC, Zuiker R, van Gerven JMA, Gross N, Yang R, Fetell M, Gershon A, Gilgun-Sherki Y, Hellriegel E, Spiegelstein O (2019) Central nervous system effects of the histamine-3 receptor antagonist CEP-26401, in comparison with modafinil and donepezil, after a single dose in a cross-over study in healthy volunteers. Br J Clin Pharmacol 85:970\u2013985. https:\/\/doi.org\/10.1111\/bcp.13885","journal-title":"Br J Clin Pharmacol"},{"key":"2047_CR49","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2174\/156720512800492530","volume":"9","author":"M Egan","year":"2012","unstructured":"Egan M, Yaari R, Liu L, Ryan M, Peng Y, Lines C, Michelson D (2012) Pilot randomized controlled study of a histamine receptor inverse agonist in the symptomatic treatment of AD. Curr Alzheimer Res 9:481\u2013490. https:\/\/doi.org\/10.2174\/156720512800492530","journal-title":"Curr Alzheimer Res"},{"key":"2047_CR50","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2174\/1567205010666131212110148","volume":"11","author":"RA Grove","year":"2014","unstructured":"Grove RA, Harrington CM, Mahler A, Beresford I, Maruff P, Lowy MT, Nicholls AP, Boardley RL, Berges AC, Nathan PJ, Horrigan JP (2014) A randomized, double-blind, placebo-controlled, 16-week study of the H3 receptor antagonist, GSK239512 as a monotherapy in subjects with mild-to-moderate Alzheimer\u2019s disease. Curr Alzheimer Res 11:47\u201358. https:\/\/doi.org\/10.2174\/1567205010666131212110148","journal-title":"Curr Alzheimer Res"},{"key":"2047_CR51","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/7854_2021_249","volume":"59","author":"T Mochizuki","year":"2022","unstructured":"Mochizuki T (2022) Histamine as an alert signal in the brain. Curr Top Behav Neurosci 59:413\u2013425. https:\/\/doi.org\/10.1007\/7854_2021_249","journal-title":"Curr Top Behav Neurosci"},{"key":"2047_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176450","volume":"968","author":"M Gao","year":"2024","unstructured":"Gao M, Dekker ME, Leurs R, Vischer HF (2024) Pharmacological characterization of seven human histamine H(3) receptor isoforms. Eur J Pharmacol 968:176450. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176450","journal-title":"Eur J Pharmacol"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-025-02047-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11307-025-02047-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-025-02047-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T18:29:45Z","timestamp":1763404185000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11307-025-02047-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["2047"],"URL":"https:\/\/doi.org\/10.1007\/s11307-025-02047-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4004389\/v1","asserted-by":"object"}]},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,12]]},"assertion":[{"value":"25 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no financial conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}